Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tons of new dd out. otcm profile changed. website now .biz not .com
new phone
new everything
im holding now!
Yeah, just to a starter as you did. Not buying more for now.
Kevin Day is a very common name it seems. From the search I did it was difficult to find him due to that fact. So I guess we just need to wait it out. Updates should be coming. :)
Yeah, hope something good will come out of it. Couldn't find anything on new CEO, so bit of a gamble
$VCII grabbed a starter yesterday. Interested to see why VCII has been reintstated after 8 years. :) Reinstated now! New officer Kevin Day
Cord Blood America Acquires Assets of NeoCells, an Illinois Stem Cell Storage Company
PRNW - 16 mins ago
LAS VEGAS , June 17, 2011 /PRNewswire/ -- Cord Blood America, Inc . ( http://www.cordblood-america.com ) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it has acquired the assets of NeoCells, a subsidiary of ViviCells International, Inc., Evanston, Illinois , through a foreclosure procedure at a purchase price of $320,000 .
An excerpt from the filing states, "The Company proceeded …. to foreclose against all assets of NeoCells. At the public disposition of all property owned by NeoCells, the Company as a secured creditor bid $320,000 in offset debt, and acquired all right, title and interest in said property free and clear of any liens, security interests and encumbrances which are junior and subordinate to the Company's security interest as a secured creditor."
"This is good news for our growth. CBAI has been highly acquisitive for a distinct reason. In today's environment, with lots of companies struggling, we have found acquiring samples to be a very effective means to improve company gross margins," Mr. Schissler said.
"With this foreclosure, Cord Blood America has now added more than 2,700 customers this year through acquisition alone, not counting organic growth, including the previous purchase in February of all the umbilical cord blood samples from Reproductive Genetics Institute, Inc., also in Illinois ," Mr. Schissler said. "All customers have had their umbilical cord blood stem cells, which were saved at birth, moved to our Las Vegas headquarters," said Matthew Schissler , co-founder and CEO. "We've assumed the cryogenic storage of these samples, and billings from their contracts. We are excited to welcome the NeoCells customers to the Cord Blood America family."
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/ . For investor information, visit http://www.cordblood-america.com/ .
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc
ViviCells International Acquisition
On May 5, 2010, the Company executed and funded a Debtor-In-Possession loan agreement with ViviCells International, Inc. a Florida corporation (“Vivi” or the “Debtor”), NeoCells, Inc., an Illinois corporation, and AdultCells, Inc., an Illinois corporation, (jointly and severally referred to as the “Subsidiaries”), for $200,000 secured by a super priority lien on the Debtor’s and Subsidiaries’ assets. As additional consideration for this loan, the Company received 21% of the Debtor’s outstanding Common Stock. The $200,000 loan carries interest at 10% per annum, with principal and all accrued interest all due and payable on March 15, 2011. In September 2010, the Company acquired an approximately $800,000 secured obligation of the Debtor held by a junior lien holder in ViviCell’s bankruptcy proceeding, in exchange for the private issuance of 11,111,111 restricted shares of its Common stock to the holder of this secured obligation.
On October 20, 2010, the Company as a co-proponent proposed a Plan of Reorganization for Vivi under the United States Bankruptcy Code, pursuant to which the Company proposed to acquire an additional 74% of the outstanding shares of Vivi, which would give it in excess of 94% ownership in ViVi, in exchange for the issuance of up to 64,488,889 shares of the Company’s common stock, and the Company’s agreement to make an additional senior secured loan in the amount of $300,000 to Vivi as working capital upon consummation of the Plan. Between June 16, 2010 and December 14, 2010, the Company accelerated the date of its loan commitment, and loaned $100,000 out of the proposed $300,000 loan amount to Vivi in advance of the Plan confirmation, secured under the super priority lien. On February 16, 2011, a hearing on Confirmation of this proposed plan of reorganization was heard and approved. The plan was scheduled to be Effective as of April 1, 2011. However, Vivi has subsequently advised the Company that it would be unable to supply the full 94% plus ownership of Vivi’s outstanding capital stock to the Company as required under the Plan. On April 13, 2011, the Company filed a Non Consummation of Confirmed Plan with the United States Bankruptcy Court. The Company pursued its rights to foreclose as the holder of a super priority lien against all assets of NeoCells, ViviCells’ subsidiary. Then, on April 22, 2011, ViviCells filed an adversary proceeding against the Company, in the same United States Bankruptcy Court, Central District of California (Santa Ana), where ViviCells bankruptcy proceedings had been taking place. ViviCells followed this by filing a Motion for a temporary restraining order on April 25, 2011, seeking to halt the foreclosure by the Company on the assets of NeoCells. The complaint and the motion were amended on May 2, 2011, primarily by adding NeoCells, in addition to ViviCells, as a party to the adversary proceeding and the motion. The motion was heard on May 2, 2011. The motion was denied, and accordingly, the Company proceeded on May 2, 2011 at 1:00 pm (CST) to foreclose against all assets of NeoCells. At the public disposition of all property owned by NeoCells, the Company as a secured creditor bid $320,000 in offset debt, and acquired all right, title and interest in said property free and clear of any liens, security interests and encumbrances which are junior and subordinate to the Company’s security interest as a secured creditor.
Cord has a non-controlling equity investment in ViviCells International, Inc., a privately held company in the business of providing blood stem cell and adult peripheral blood stem cell preservation services. The Company utilizes the equity method of accounting as it owns more than 20% of the outstanding common stock and has the ability to exercise significant influence over this company. As such, the investment is carried at cost less Cord’s proportionate share of ViviCells net loss for the period since investment. At March 31, 2011, the carrying amount of this investment is $0.
Good stem cell coverage this weekend by Fox news. the story touted the benefits of storing cord blood and can be viewed as positive promotion for all stem cell storage companies.
http://video.foxnews.com/#/v/4623297/should-you-save-your-babys-cord-blood/?playlist_id=87485
On October 20, 2010, the Company as a co-proponent proposed a Plan of Reorganization for Vivi under the United States Bankruptcy Code, pursuant to which the Company proposed to acquire an additional 74% of the outstanding shares of Vivi, which would give it in excess of 94% ownership in ViVi, in exchange for the issuance of up to 64,488,889 shares of the Company’s common stock, and the Company’s agreement to make an additional senior secured loan in the amount of $300,000 to Vivi as working capital upon consummation of the Plan. Between June 16, 2010 and December 14, 2010, the Company accelerated the date of its loan commitment, and loaned $100,000 out of the proposed $300,000 loan amount to Vivi in advance of the Plan confirmation, secured under the super priority lien. On February 16, 2011, a hearing on Confirmation of this proposed plan of reorganization was heard and approved. The plan is scheduled to be Effective as of April 1, 2011. However, Vivi has subsequently advised the Company that it would be unable to supply the full 94% plus ownership of Vivi’s outstanding capital stock to the Company as required under the Plan. The Company has advised Vivi that unless the full 94% plus ownership of Vivi capital stock can be delivered to the Company as required under the Plan, the Company will declare a default under the Plan and pursue its rights to foreclose as the holder of a super priority lien against all Vivi assets and all assets of the Subsidiaries
ViviCells International Acquisition
On May 5, 2010, the Company executed and funded a Debtor-In-Possession loan agreement with ViviCells International, Inc. a Florida corporation (“Vivi” or the “Debtor”), NeoCells, Inc., an Illinois corporation, and AdultCells, Inc., an Illinois corporation, (jointly and severally referred to as the “Subsidiaries”), for $200,000 secured by a super priority lien on the Debtor’s and Subsidiaries’ assets. As additional consideration for this loan, the Company received 21% of the Debtor’s outstanding Common Stock. The $200,000 loan carries interest at 10% per annum, with principal and all accrued interest all due and payable on March 15, 2011. In September 2010, the Company acquired an approximately $800,000 secured obligation of the Debtor held by a junior lien holder in ViviCell’s bankruptcy proceeding, in exchange for the private issuance of 11,111,111 restricted shares of its Common stock to the holder of this secured obligation
It could do the same again up to .51.Read.THIS STOCK RUN FROM .02 IN JANUARY 26TH 2009 TO .51 IN JANUARY 28TH 2009 in just two days.WITH VOLUMES OF LESS THATN 90K.
Wish I knew Steve,Take Profits for sure look back at the Trading History and you will see lots of Gaps
Hey Locks....this just keeps going up... I bought back in April and have a 500% gain. Any idea where this is going to go...and how it will end up later this year after the take over by CBAI?
TIA
More good dd.
Chin up. You'll be out in no time!
It is in Bankruptcy-CBAI On May 5, 2010, the Company executed and funded a Debtor-In-Possession loan agreement with ViviCells International, Inc. a Florida corporation (“Vivi”), NeoCells, Inc., an Illinois corporation, and AdultCells, Inc., an Illinois corporation, (jointly and severally referred to as the “Subsidiaries”). This loan was done in conjunction with the Company's preparation as a co-proponent of a Plan of Reorganization under the United States Bankruptcy Code, pursuant to which the Company proposes ultimately hold 95% of the outstanding shares of Vivi and thereby acquiring its business and assets, in exchange for the issuance of up to 75.6 million shares of restricted Company common stock. Pursuant to the terms of the Debtor-in Possession Loan Agreement t he Company loaned Vivi the principal amount of $200,000. The loan carries interest at 10% per annum, with principal and all accrued interest all due and payable on March 15, 2011. The debtor in this agreement and its two subsidiaries, each pledged all their assets and business to secure the loan, and agreed that the loan would have senior security status.
Hey Steve its odd CBAI buys VCIIs debt and has 10% of AXMP storage contract and both of them spiked up at the same time! ODD
Locks, just speculation....that I happen to agree with.
CBAI is involved here and Cbai also is Dealing with AXMP that just ran up 113 percent.These Companys must have an info CBAI hasnt given out yet!
History of ViviCells International, Inc. (VCII)
http://www.reuters.com/finance/stocks/chart?symbol=VCII.PK
Florida Business Entity #650596319
Formed on 7/7/95 as Kenwick Inc.
http://www.sunbiz.org/scripts/cordet.exe?action=DETFIL&inq_doc_number=P95000053188&inq_came_from=NAMFWD&cor_web_names_seq_number=0004&names_name_ind=N&names_cor_number=&names_name_seq=&names_name_ind=&names_comp_name=VIVICELLS&names_filing_type=
7/30/98 Kenwick Inc. changed it's name to Kenwick Industries Inc.
11/18/99 Kenwick Industries Inc registered it's securities with the SEC and started out on the OTC-BB
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001075055&type=&dateb=&owner=include&count=40
6/12/02 Kenwick Industries Inc. de-registered it's securities moving it off the OTC and onto the Pink Sheets (this is the last filing that has ever been done by this company with the SEC)
8/13/03 Kenwick Industries Inc. changed it's name to Southern California Beverage Corp
http://www.sunbiz.org/pdf/%5C0021232.pdf
9/5/03 Kenwich Industries Inc (KWIN) changed it's symbol to (SBVG) and did a 1-150 reverse split (no filings were done with the SEC)
http://www.otcbb.com/asp/dailylist_detail.asp?d=09/04/2003&mkt_ctg=NON-OTCBB
9/8/03 Southern California Beverage Corp filed a Reg D
http://www.sec.gov/cgi-bin/browse-edgar?company=Southern+California+Beverage+Corp&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
9/10/03 Southern California Beverage Corp changed it's name to Tropical Beverage Inc. and changed it's officers to Chris Lotito and Mark Millsap:
http://www.sunbiz.org/pdf/%5CH027254.pdf
9/15/03 Southern California Beverage Corp (SBVG) changed it's symbol to (TPBV) (no filings done with the SEC)
http://www.otcbb.com/asp/dailylist_detail.asp?d=09/12/2003&mkt_ctg=NON-OTCBB
Tropical Beverage put out several pay to print press releases over the next 4 years always pumping the company but rarely giving any details
This is interesting - 3/31/04 when and amendment was filed with the state of Florida raising the number of authorized shares the attorney that signed the letter was Michael Spadaccini. He is the same lawyer that was involved in the US Wind Farming scandal in 2006 with Raymond J. McNamee. Michael Spadaccini registered several of the businesses entities that were used to sell unregistered shares to the public to make money off the scam. He himself was gifted unregistered shares to sell.
http://www.sunbiz.org/pdf/70497247.pdf
http://www.sec.gov/litigation/litreleases/2006/lr19802.htm
http://www.sec.gov/litigation/complaints/comp19311.pdf
http://www.sec.gov/litigation/complaints/2006/comp19802.pdf
Chris Lotito filed a news release saying he had hired Michael Spadaccini to get the company fully reporting (which obviously never happened)
http://www.allbusiness.com/legal/legal-services-lawyers/5597945-1.html
No 2004 annual report was filed and the company went into bad standing with the state of Florida.
10/28/04 they filed to have the company reinstated again.
http://www.sunbiz.org/pdf/70296997.pdf
11/1/04 Tropical Beverage Inc. filed a Reg D: (don't really get the misspelled name or the late date of the filing)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001307698&owner=exclude&count=40
11/10/04 Tropical Beverage Inc. put out a press release saying it was teaming up with Nutmeg Group Inc. (who was paying them $1,000,000) to expand and get back on the OTC exchange: (they never filed anything and never got back to the OTC)
http://www.allbusiness.com/marketing-advertising/marketing-techniques/5546258-1.html
The company failed to file it's 2006 annual report and went into bad standing again in the state of Florida.
During the next 2 years press releases continue to go out for the company. They have some legal issues with Nutmeg Group Inc who accuses them of frauded investors with false statements/press releases while giving themselves lots of unreported shares which were then sold through other business entities and the money kept in separate bank accounts away from the Tropical Beverage Inc books.
http://siliconinvestor.advfn.com/readmsg.aspx?msgid=22137405
http://www.allbusiness.com/legal/legal-services-litigation/5379249-1.html
Looks like the case was suspended/terminated pending bankruptcy by the Tropical Beverage Inc.
http://www.legalmetric.com/cases/securities/ilnd/ilnd_106cv01011.html#s29
5/15/07 they filed to be reinstated
4/21/08 a merger was filed between Tropical Beverage and ViviCells International Inc from Illinois
http://www.sunbiz.org/pdf/00099568.pdf
5/9/08 Tropical Beverage Inc., (TPBV) changed it's symbol to (VCII) and did a 1:140 reverse split (no filings were done with the SEC)
http://www.otcbb.com/asp/dailylist_detail.asp?d=05/08/2008&mkt_ctg=NON-OTCBB
No 2009 annual report was filed and the company went into bad standing again in the state of Florida
10/19/2009 they filed to be reinstated
http://www.sunbiz.org/pdf/61892644.pdf
May 5, 2010 Cord Blood America, Inc. executed and funded a Debtor-In-Possession loan agreement with ViviCells International, Inc. a Florida corporation (“Vivi”), NeoCells, Inc., an Illinois corporation, and AdultCells, Inc., an Illinois corporation, (jointly and severally referred to as the “Subsidiaries”). This loan was done in conjunction with the Company's preparation as a co-proponent of a Plan of Reorganization under the United States Bankruptcy Code, pursuant to which the Company proposes ultimately hold 95% of the outstanding shares of Vivi and thereby acquiring its business and assets, in exchange for the issuance of up to 75.6 million shares of restricted Company common stock. Pursuant to the terms of the Debtor-in Possession Loan Agreement t he Company loaned Vivi the principal amount of $200,000. The loan carries interest at 10% per annum, with principal and all accrued interest all due and payable on March 15, 2011. The debtor in this agreement and its two subsidiaries, each pledged all their assets and business to secure the loan, and agreed that the loan would have senior security status.
http://www.sec.gov/Archives/edgar/data/1289496/000135448810002658/cbai_10q.htm
9/24/10 they went back into bad standing again in the state of Florida for not filing the 2010 annual report
They are currently an inactive business entity in the state of Florida
They are not currently in good standing in the state of Illinois either.
No filings were ever done with the SEC since 2001 despite 3 name changes and 3 symbol changes
Both Chris Lotito and Raymond J. McNamee were involved in the PTRZ scam and that's what led me to the ViviCell International, Inc. forum. I was just looking for any additional information that could be found.
correction from my post - pink sheet stock labeled Caveat Emptor
Can somebody explain to me how this company has managed to not get revoked despite not filing anything with the SEC since 2001?
It's changed names 3 times since then from Kenwick Industries Inc to Southern California Beverage Corp to Tropical Beverage Inc to ViviCells International Inc.
I realize it's a grey sheet stock labeled Caveat Emptor but it seems like 9 years is enough to be revoked completely.
Why does this company refuse to disclose anything to the SEC, it's investors, and the general public?
Chris Lotito has been involved in some very similar stock deals where companies changed named without filing properly and promptly got suspended and moved to the grey sheets.
He's had some close business associates that have gotten in lots of trouble for pump and dump schemes. Which is what led me to this board.
Just wanted to get an idea about what I might be missing about this stock that would help me understand better if this was another example of the same people pulling another similar scam or not back in May of 2008.
Who knows, it's been utterly silent since the giant R/S when they stopped being a California soda pop company ?!
volume 146,829 today...something going on ?
No its not because of the lift on Federal Funds for Research.Also Tomorrow is Saturday maybe Monday.
It could be that today's spike was in some way related to the lift of ban on stem cell funding:
http://voices.washingtonpost.com/checkup/2010/09/appeals_courts_lifts_ban_on_st.html
http://www.washingtonpost.com/wp-dyn/content/article/2010/09/09/AR2010090905730.html
If that's the case it may continue to run in the coming days. I guess we'll just have to see what tomorrow brings.
That's right, I recall that now! Thanks Locks.
On May 5, 2010, the Company executed and funded a Debtor-In-Possession loan agreement with ViviCells International, Inc. a Florida corporation (“Vivi”), NeoCells, Inc., an Illinois corporation, and AdultCells, Inc., an Illinois corporation, (jointly and severally referred to as the “Subsidiaries”). This loan was done in conjunction with the Company's preparation as a co-proponent of a Plan of Reorganization under the United States Bankruptcy Code, pursuant to which the Company proposes ultimately hold 95% of the outstanding shares of Vivi and thereby acquiring its business and assets, in exchange for the issuance of up to 75.6 million shares of restricted Company common stock. Pursuant to the terms of the Debtor-in Possession Loan Agreement t he Company loaned Vivi the principal amount of $200,000. The loan carries interest at 10% per annum, with principal and all accrued interest all due and payable on March 15, 2011. The debtor in this agreement and its two subsidiaries, each pledged all their assets and business to secure the loan, and agreed that the loan would have senior security status.
Yes, I saw that too. But do you know if he wants to buy it? I know he was in Chi-town just a few months back.
It wont matter here when Matt buys this.Looks like the History has a run every so often http://ih.advfn.com/p.php?pid=historical&symbol=VCII
IDK, that's a year old. I think this moves when the wind blows because of the limited amount of shares available. Do you all see anything different? I own a very small handful.
Last filing with the FL secretary of state shows reinstatement
http://www.sunbiz.org/scripts/cordet.exe?action=DETFIL&inq_doc_number=P95000053188&inq_came_from=NAMFWD&cor_web_names_seq_number=0004&names_name_ind=N&names_cor_number=&names_name_seq=&names_name_ind=&names_comp_name=VIVICELLS&names_filing_type=
not sure, but has some interest...
Nice call. Something brewing perhaps?
The TA wouldnt say about Restricted and he said they wont be reporting
Agreed. I need to add another handful before that happens.
Sure was...need a few more with increased volume and we are good-to-go.
That core group is most likely the current crop chatting on the board. Wonder what's up?
This company is caveat emptor. Dark. They need to start reporting.
In Reply To 'halpern6'
the OBV appears to indicate a core group of buyers, really loading up early in April, when the last spike took place, and most of them still holding...there has to be something cooking. Best case scenario would be big pharma looking for an aquisition or merger, as they've done in other cases, a huge government grant would work too....IMO.
the OBV appears to indicate a core group of buyers, really loading up early in April, when the last spike took place, and most of them still holding...there has to be something cooking. Best case scenario would be big pharma looking for an aquisition or merger, as they've done in other cases, a huge government grant would work too....IMO.
Mystery to me. I bought 10,000 shares here several years ago when it was 'Tropical Beverage' a highly pumped southern California bottled water and soft drink producer. Now, after the R/S a few years ago it's Vivicells International Inc., and dead in the water. Oh, and my 10,000 shares are now 72 shares. Typical pink, I guess.
Seems we are on the same page...now we just wait. I too got a small amount a few days ago and feel luck to have grabbed them at .012.
GLTU
My thoughts exactly. I got a small handful at .013 yesterday.
Followers
|
27
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1047
|
Created
|
05/09/04
|
Type
|
Free
|
Moderators |
ViviCells International Inc (VCII)
Company Information:
2142 Ashland Avenue
Suite # 2
Evanston, IL 60201 USA
800.807.9539
CIK: 0001075055
ViviCells International, Inc. is the nation’s first and only comprehensive family stem cell bank.
The ViviCells philosophy - Preserving stem cells from birth through life™ means people should have access to high quality umbilical cord blood and adult peripheral stem cell preservation services at affordable prices.
NeoCells and AdultCells operating subsidiaries
NeoCells Affordable Cord Blood Banking As Seen In... | |||||||||||||||
![]() | ![]() | ![]() | ![]() | ![]() |
1. What is unique about NeoCells?
NeoCells is “America’s high quality yet affordable umbilical cord blood stem cell preservation company.” We have the most reasonable and affordable price, while providing the same quality assurance and the same rigorous scientific and regulatory laboratory controls and service as the considerably higher priced cord blood preservation companies. NeoCells and ViviCells, its parent company, is committed to the belief that cord blood stem cell preservation technology should be made available at an affordable cost to as many families as possible – not just to those for whom price is no deterrent. Unfortunately, many families who would like to have access to this service and who need this service cannot afford the prices of other high-cost private cord blood banks. NeoCells carefully controls its costs, and unlike the high-priced cord blood banks does not add in an unfair high profit margin, and does not inflate its price only to later offer discounts, client gifts and inducements to purchase in an effort to make a high price appear more palatable. NeoCells sets an affordable price and relies on volume due to the company’s exponential growth. NeoCells also distinguishes itself from most cord blood banking companies by using state-of-the-art processing and cryogenic freezing and storage technology which includes the AXP AutoXpress Platform and the Sepax Processing System which are functionally closed bag stem cell processing systems. These are the methods recommended by the FDA and the AABB due to research which has shown higher total mononuclear cell recovery averages* and higher yields for viable CD34+ cells. (*Averages range from 87%-97% vs. alternative manual methods which yield only 40%-80%). NeoCells further believes the decision to select the cord blood preservation company they would like to store their newborn’s stem cells with should rest with the child’s parents. As such, NeoCells also differs markedly from some of the other cord blood companies in that NeoCells does not make a practice of paying physicians and other health care providers to recommend the NeoCells cord blood preservation services.
AdultCells is America’s first commercial autologous (self donated for self use) adult peripheral blood stem cell collection and preservation company to offer a conventional natural and convenient adult peripheral blood stem cell collection, process and preservation service on the national level. Thanks to our proprietary technology, AdultCells makes pre-disease stem cell collection for healthy adults easy, safe and affordable for everyone.
ViviCells International, LLC Launches the Nation's First and Only Comprehensive Family Stem Cell Bank
ViviCells International, LLC Launches the Nation's First and Only Comprehensive Family Stem Cell Bank
ViviCells International, LLC announces the launch of its two subsidiary companies, NeoCells, LLC and AdultCells, LLC . This makes it the nation's first and only family stem cell bank. AdultCells, with its proprietary technology is the first company to collect and store stem cells from adult peripheral blood for people who have missed the opportunity to harvest their umbilical cord stem cells. NeoCells, focusing on umbilical cord blood collection and cryopreservation is the country's most affordable cord blood preservation company.
Evanston, Illinois (PRWEB) May 24, 2006 -– ViviCells International, LLC announces the launch of its two subsidiary companies, NeoCells, LLC and AdultCells, LLC, making it America's premier and only comprehensive national family stem cell bank. AdultCells, with its proprietary technology is the first and only company to collect and store stem cells using convenient and natural means from adult peripheral blood for people who have missed the opportunity to harvest their umbilical cord stem cells. NeoCells, focusing on umbilical cord blood collection and cryopreservation is the country's most affordable cord blood preservation company.
CEO and founder, Fred Fitzsimmons states, "The launching of NeoCells and AdultCells is groundbreaking innovation that will allow families to store their newborn's umbilical cord blood stem cells as well as their own healthy adult blood stem cells for future use, and do so at an affordable cost."
Scientific Directors, Anver Kuliev, M.D., PhD and Gennady Tsukerman, M.D., PhD are leading the way with their proprietary technology that will allow the reprogramming of cells extracted from the blood to potentially be used to treat diseases in the future. "We are excited to see that stem technology has already been made available for treatment of severe congenital bone marrow failures and we may expect stem cell technology's wider practical applications in the near future," says Dr. Kuliev, the former head of the World Health Organization Genetics Program, who is currently operating the World Health Organization Collaborating Center for the Prevention of Genetic Disorders.
Stem cell therapy is a rapidly growing industry and umbilical cord blood collection and storage has been available commercially to the public since 1992. Presently, there are dozens of different disorders that are being treated with stem cell therapy and several others are already in phase II and phase III clinical trials in the U.S. These include current research on heart disease, stroke, diabetes, spinal cord injuries, multiple sclerosis, Parkinson's, Lupus and many more.
Julianne Hearst, one of NeoCells' first clients explains, "I feel a sense of assurance knowing that my child's stem cells have been collected and cryopreserved. I hope that we won't need to use them in the future, but we can be confident that they will be available in the future should the need arise. I've been so satisfied with the NeoCells service and affordable price that my husband and I are now planning on using AdultCells to collect and store our own adult peripheral blood stem cells."
For additional information on the news that is the subject of this release, please contact Renee Fitzsimmons or visit www.AdultCells.com or www.NeoCells.com
About ViviCells International, LLC
ViviCells International, LLC is the only international stem cell preservation company currently committed to providing entire families, from newborns to adults, with the highest quality and most affordable stem cell services through its combined NeoCells and AdultCells operating subsidiaries. ViviCells management experience spans more than forty years in the health care industry consisting of proven pioneering staff assembled from the cord blood and adult peripheral blood stem cell preservation fields.
About AdultCells, LLC
AdultCells, LLC is a subsidiary company of ViviCells International, LLC and is the premier company to provide adult stem cell collection, testing, processing, cryopreservation and storage from adult peripheral blood. Corporate headquarters are in Evanston, Illinois and Sales and Client Support are in Palm Harbor, Florida. Client Support can be reached at 1.888.38.CELLS (1.888.382.3557).
About NeoCells, LLC
NeoCells, LLC is a subsidiary company of ViviCells International, LLC and provides umbilical cord blood stem cell collection, testing, processing, cryopreservation and storage at the nation's most affordable price. Corporate headquarters are in Evanston, Illinois and Sales and Client Support are in Palm Harbor, Florida. Client Support can be reached at 1.888.50.CELLS (1.888.502.3557).
Contact:
Renee Fitzsimmons, Director of Educational Services
ViviCells International, LLC
1.800.807.9539 ext. 105
www.AdultCells.com
www.NeoCells.com
Filings: Company is dark
http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001075055&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Transfer Agent:
Florida Atlantic Stock Transfer, Inc.
7130 Nob Hill Road
Tamarac, FL 33321
Share Structure:
Share count per T.A. is 90,639,595 O/S as of 4/09/2010 2:56pm
(with over 85m restricted as per CEO)
Investor Relations:
800.807.9539
ViviCells.com
Help@ViviCells.com
Last update 4.09.2010
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |